Parkinson's disease is not one disease

Parkinsonism and Related Disorders

Volumn 7, Issue 1, 2000, Pages 3-7

  Calne, D B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Idiopathic Parkinsonism; Parkinson's disease; Syndrome

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL DEATH; CHROMOSOME 2P; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; HEREDITY; LEWY BODY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033800917     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00042-0     Document Type: Article

References (51)

1. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 32:1992;S125-S127.
2. Hassler R. Zur pathologie der paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol. 48:1938;387-476.
3. Fearnley J., Lees A. Pathology of Parkinson's disease. Calne D.B. Neurodegenerative diseases. 1994;545-554 W.B. Saunders, Philadelphia.
4. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 40:1990;1-8.
5. Dooling E., Schoene W., Richardson E. Hallervorden-Spatz syndrome. Arch Neurol. 30:1974;70-83.
6. Gibb W.R.G., Scaravilli F., Michaud J. Lewy bodies and subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry. 53:1990;310-311.
7. Rajput A.H., Uitti R.J., Sudhakar S., Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol. 25:1989;602-606.
8. Ishikawa A., Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile Parkinsonism. J Neurol. 245:1998;4-9.
9. Pal P.K., Samii A., Lieberman A., Nausieda P.A., Calne D.B., Stoessl A.J. [18F]-Dopa PET in early stage Juvenile Parkinsonism. Parkinsonism Related Disord. 5:1999;S63.
10. de la Fuente-Fernandez R., Schulzer M., Mark E., Kishore A., Calne D.B. The role of the Lewy body in idiopathic Parkinsonism. Parkinsonism Related Disord. 4:(2):1998;73-77.
11. Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism Related Disord (Translation). 4:(1):1998;53-57.
12. Sano I. Biochemistry of the extrapyramidal system. Shinkei Kennkyu No Shinpo. Adv Neurol Sci. 5:1990;42-48.
13. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. The N Engl J Med. 318:(14):1988;876-880.
14. Snow B.J., Tooyama I., McGeer E.G., Yamada T., Calne D.B., Takahashi H., Kimura H. Human positron emission tomographic [18F] fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol. 34:1993;324-330.
15. Pate B.D., Kawamata T., Yamada T., McGeer E.G., Hewitt K.A., Snow B.J., Ruth T.J., Calne D.B. Correlation of striatal fluorodopa uptake in MPTP monkey with dopaminergic indices. Ann Neurol. 34:1993;331-338.
16. Lee C.S., Samii A., Sossi V., Ruth T.J., Schulzer M., Calne D.B., Stoessl A.J. Effect of striatal dopaminergic denervation on [18F] FDOPA-, [11C]DTBZ-, and [11C] MP-PET scans: a comparative study in patients with Parkinson's disease. Neurology. 52:(6 (suppl. 2)):1999;A175.
17. Birkmayer W., Riederer P., Youdim M.B.H. Distinction between benign and malignant type of Parkinson's disease. Clin Neurol Neurosurg. 81:(3):1979;158-164.
18. Lee C.S., Schulzer M., Mak E.K., Snow B.J., Tsui J.K., Calne S., Hammerstad J., Calne D.B. Clinical observations on the rate of progression of idiopathic Parkinsonism. Brain. 117:1994;501-507.
19. Strange P. Biochemical characterization of dopamine receptors. Neve K.A., Neve R.L. The dopamine receptors. 1997;3-26 Humana Press, Totowa, NJ.
20. Mjones H. Paralysis agitans. A clinical genetic study. Acta Psychiatr Neurol Scand. 54:1949;1-195.
21. Calne S., Schoenberg B., Martin W., Uitti R.J., Spencer P., Calne D.B. Familial Parkinson's disease: possible role of environmental factors. Can J Neurol Sci. 14:1987;303-305.
22. Uitti R.J., Shinotoh H., Hayward M., Schulzer M., Mak E., Calne D.B. Familial Parkinson's disease - a case-controlled study of families. Can J Neurol Sci. 24:1997;127-132.
23. Golbe L.I. positron emission tomography reveals strong genetic influence in Parkinson's disease. Ann Neurol. 45:1999;557-558.
24. Piccini P., Burn D.J., Ceravolo R., Maraganore D., Brooks D.J. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol. 45:1999;577-582.
25. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins. An etiological study. JAMA. 281:1999;341-346.
26. Duvoisin R.C. Recent advances in the genetics of Parkinson's disease. Battistin L., Scarlato G., Caraceni T., Ruggieri S. Parkinson's disease. Advances in neurology. vol. 66:1996;33-40 Lippincott-Raven, Philadelphia.
27. Denson M.A., Wzolek Z. Familial Parkinsonism: our experience. Parkinsonism Related Disord. 1:(1):1995;35-47.
28. Muenter M.D., Forno L.S., Hornykiewicz O., Kish S.J., Maraganore D.M., Caselli R.J., Okazaki H., Howard F.M., Snow B.J., Calne D.B. Hereditary form of Parkinsonism - dementia. Ann Neurol. 43:1998;768-781.
29. Samii A., Markopoulou K., Wszolek Z.K., Sossi V., Dobko T., Mak E., Calne D.B., Stoessl A.J. Position emission tomographic studies of family H: a Greek-American kindred with autosomal dominant levodopa responsive Parkinsonism secondary to a mutation of alpha-synuclein. Neurology. 1999;. (in press).
30. Wszolek Z.K., Uitti R.J. The clinical genetics of Parkinson's disease. Neurosci News. 2:1999;66-72.
31. Polymeropoulos M.H., Levedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
32. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. Nature. 392:1998;605-608.
33. Gasser T., Wszolek Z.K., Trofatter J., Ozelius L., Uitti R.J., Lee C.S., Gusella J., Pfeiffer R.F., Calne D.B., Breakefield X.O. Genetic linkage studies in autosomal dominant Parkinsonism: evaluation of seven candidate genes. Ann Neurol. 36:(3):1994;387-396.
34. Vingerhoets F.J.G., Snow B.J., Tetrud J.W., Langston J.W., Schulzer M., Calne D.B. Positron emission tomography evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol. 36:1995;765-770.
35. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol. 46:1999;598-605.
36. Martin W.R.W., Adam M.J., Bergstrom M., Ammann W., Harrop R., Laihinen A., Rogers J., Ruth T., Sayre C., Stoessl A.J., Pate B.D., Calne D.B. In vivo study of DOPA metabolism in Parkinson's disease. Fahn S., Marsden C.D., Jenner P., Teychenne P. Recent developments in Parkinson's disease. 1986;97-102 Raven Press, New York.
37. Gamboa E.T., Wolf A., Yahr M.D., Barden H., Hsu C.C., Duff P.E., Harter D.H. A influenza virus as a possible cause of postencephalitic Parkinsonism. Trans Am Neurol Assoc. 98:1973;177-180.
38. Yamada T. Viral etiology of Parkinson's disease: focus on influenza A virus. Parkinsonism Related Disord. 2:(3):1996;113-123.
39. Lin S.K., Lu C.S., Vingerhoets F.J.G., Snow B., Schulzer M., Wai Y.Y., Chu N.S., Calne D.B. Isolated involvement of substantia nigra in acute transient Parkinsonism: MRI and PET observations. Parkinsonism Related Disord. 1:(2):1995;67-73.
40. Marion S.A., Schulzer M., Calne D.B., Wang Y., Tsui J.K.C. Occupational risk factors in Parkinson's disease. Parkinsonism Related Disord. 5:1999;S46. (abstract).
41. Kurtzke J.F., Goldberg I.D. Parkinsonism death rates by race, sex, and geography. Neurology. 38:1988;1558-1561.
42. Calne D.B., Lees A.J. Late progression of post-encephalitic Parkinson's syndrome. Can J Neurol Sci. 15:1988;135-138.
43. Gibb W.R.G., Lees A.J. The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic Parkinsonian syndrome. Acta Neuropathol. 73:1987;195-201.
44. Symonds C. Concussion and its sequelae. Symonds C. Studies in neurology. 1970;143-152 Oxford University Press, London.
45. Boxing Brains Editorial, The Lancet 1973:1064-1065.
46. Bruetsch W.L., DeArmond M. The Parkinsonian syndrome due to trauma. J Nerv Ment Dis. 18:1935;531-543.
47. Schulzer M., Lee C.S., Mak E.K., Vingerhoets F.J.G., Calne D.B. A mathematical model of pathogenesis in idiopathic Parkinsonism. Brain. 117:1994;509-516.
48. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease of brains. Neurology. 38:1988;1285-1291.
49. Calne D.B. Is "Parkinson's disease" one disease. J Neurol Neurosurg Psychiatry. 52:1989;18-21.
50. Duvoisin R.C. Is there a Parkinson's disease? Quinn N.P., Jenner P. Disorders of movement. 1989;1-10 Academic Press, London.
51. Korczyn A.D. Cognitive dysfunction: the spectrum of Parkinsonian syndromes. Wolters E.C., Scheltens P., Berendse H.W. Mental dysfunction in Parkinson's disease. 1999;209-214 Academic Pharmaceutical Productions, The Netherlands.